EUVIMED · CrossrefZeitschrift
Anti-Cancer Drugs
ISSN 0959-4973 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Predictors of cervical lymphatic spread in papillary thyroid microcarcinoma: clinical and pathological determinants
Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report
Isovanillin regulates gastric cancer cells apoptosis and metastasis by targeting ROS-mediated MAPK and PI3K signaling pathways
Dauricine induces ferroptosis in neuroblastoma by inhibiting methyltransferase-like 1-mediated N7-methylguanosine methylation of solute carrier family 3 member 2
Activation of the caspase-1/gasdermin D pathway via α-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth
Overcoming refractory leptomeningeal metastasis in nonsmall cell lung cancer with intrathecal pemetrexed and osimertinib: a case report
Early sensitivity and rapid resistance to drug therapy in primary pulmonary nuclear protein in testis carcinoma
Nivolumab- and ipilimumab-induced myositis, myasthenia gravis, and myocarditis in a patient with metastatic melanoma
A dual thermo/pH-sensitive hydrogel as 5-Fluorouracil carrier for breast cancer treatment
A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinib
Upregulation of CDC25B by transcription factor TEAD4 drives invasion and inhibits cisplatin sensitivity through cell adhesion in stomach adenocarcinoma
Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation
TRIM11 expression levels was downregulated and prevents ferroptosis of cardiomyocyte by Dusp6 in acute myocardial infarction
CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma
Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells
Early dose reduction of osimertinib in advanced EGFR-mutated non-small cell lung cancer
Targeting HSP47 for cancer treatment
HMOX1 regulates ferroptosis via mic14 and its impact on chemotherapy resistance in small-cell lung cancer
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma
APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by NRF2/HO-1
Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K/AKT/MAPK signaling pathway
Tumor neoantigens derived from RNA editing events show significant clinical relevance in melanoma patients treated with immunotherapy
Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation
CLIC1-mediated autophagy confers resistance to DDP in gastric cancer
Treatment of neurofibromatosis type II with anlotinib: a case report and literature review
Pemetrexed long-term maintenance therapy for advanced severe lung cancer with long-term progression-free survival: a case report
Methyltransferase-like 3 enhances cell proliferation and cisplatin resistance in natural killer/T-cell lymphoma through promoting N6-methyladenosine modification and the stability of staphylococcal nuclease and Tudor domain-containing protein 1 mRNA
Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy
Exosomal circ-ADRM1 promotes lung adenocarcinoma progression and induces macrophage M2 polarization through regulating MMP14 mRNA and protein
Successful administration of low-dose almonertinib in a patient with lung adenocarcinoma after osimertinib-induced interstitial lung disease: a case report and literature review
Jahrgänge
2026 · 642025 · 1112024 · 1292023 · 1442022 · 2442021 · 1422020 · 1472019 · 1442018 · 1232017 · 1362016 · 1342015 · 1322014 · 1412013 · 1272012 · 1362011 · 1402010 · 1262009 · 1392008 · 1322007 · 1522006 · 1592005 · 1492004 · 1322003 · 1322002 · 1372001 · 1502000 · 1171999 · 1301998 · 1211997 · 1551996 · 1751995 · 1501994 · 2571993 · 1081992 · 1091991 · 771990 · 34
EUVIMED